BCV
REGN icon

Banque Cantonale Vaudoise’s Regeneron Pharmaceuticals REGN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
1,970
+808
+70% +$619K 0.06% 307
2025
Q4 		$897K Sell
1,162
-338
-23% -$230K 0.03% 380
2025
Q3 		$844K Buy
1,500
+345
+30% +$195K 0.03% 381
2025
Q2 		$606K Sell
1,155
-1,419
-55% -$792K 0.02% 418
2025
Q1 		$1.63M Buy
+2,574
New +$1.77M 0.07% 272
2024
Q3 		$858K Sell
817
-621
-43% -$691K 0.04% 340
2024
Q2 		$1.51M Sell
1,438
-3,225
-69% -$3.13M 0.06% 276
2024
Q1 		$4.49M Buy
4,663
+1,167
+33% +$1.11M 0.18% 117
2023
Q4 		$3.07M Sell
3,496
-402
-10% -$331K 0.13% 155
2023
Q3 		$3.21M Buy
3,898
+310
+9% +$244K 0.16% 108
2023
Q2 		$2.58M Sell
3,588
-2,688
-43% -$2.07M 0.12% 144
2023
Q1 		$5.16M Buy
6,276
+3,670
+141% +$2.77M 0.25% 77
2022
Q4 		$1.88M Sell
2,606
-2,059
-44% -$1.52M 0.1% 193
2022
Q3 		$3.21M Sell
4,665
-10
-0.2% -$6.29K 0.18% 101
2022
Q2 		$2.76M Buy
4,675
+1,583
+51% +$1.03M 0.14% 136
2022
Q1 		$2.16M Sell
3,092
-2,075
-40% -$1.31M 0.09% 214
2021
Q4 		$3.26M Buy
5,167
+1,604
+45% +$986K 0.13% 152
2021
Q3 		$2.16M Sell
3,563
-219
-6% -$136K 0.09% 214
2021
Q2 		$2.11M Buy
3,782
+135
+4% +$68.4K 0.09% 220
2021
Q1 		$1.73M Buy
3,647
+425
+13% +$207K 0.09% 224
2020
Q4 		$1.56M Sell
3,222
-430
-12% -$232K 0.09% 209
2020
Q3 		$2.04M Sell
3,652
-1,538
-30% -$933K 0.13% 143
2020
Q2 		$3.24M Buy
5,190
+2,695
+108% +$1.53M 0.24% 88
2020
Q1 		$1.22M Buy
2,495
+1,243
+99% +$513K 0.1% 201
2019
Q4 		$471K Buy
+1,252
New +$421K 0.03% 485

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Banque Cantonale Vaudoise's REGN Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its Regeneron Pharmaceuticals (REGN) stake by 70% in Q1 2026, buying an estimated $619K and bringing the position to 1,970 shares worth $1.52M. The position accounts for 0.06% of the portfolio, ranked #307.

Banque Cantonale Vaudoise first reported a position in REGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.16M in Q1 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Banque Cantonale Vaudoise held 1,970 shares of Regeneron Pharmaceuticals worth $1.52M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 808 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $619K.
  • Regeneron Pharmaceuticals made up 0.06% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #307 holding.
  • Banque Cantonale Vaudoise first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's Regeneron Pharmaceuticals position peaked at $5.16M in Q1 2023.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.